Zyclara (imiquimod) - Mochida, Viatris, Bausch Health
ASP5502 - Astellas
Vitamin K3 attenuates STING-agonist-induced signaling and imiquimod-induced psoriasis-like inflammation. (PubMed, Biochem Pharmacol) - Sep 17, 2026 - "Although several potent STING inhibitors are in preclinical development and ASP5502 has entered clinical evaluation, no STING inhibitor has received regulatory approval. Among the vitamin K analogues examined, VK3 showed the most consistent attenuation of STING-agonist-induced signaling. These findings support further investigation of VK3 as a topical modulator of inflammatory signaling in skin disease." 
Journal • Dermatitis • Dermatology • Immunology • Inflammation • Psoriasis • CGAS • IL17A • IL23A • STING
http://www.ncbi.nlm.nih.gov/pubmed/42749229
 
Liang Hong; Meichen Meng; Min Li; Yiqin Zhang; Zhen Huang; Zuyi Jin
 
Sep 17, 2026
 
Prev Next